Search
Innovative Drug Momentum Persists, Weikang Pharmaceutical Reaches 20% Daily Limit
3 day ago /
Read about 0 minute
Author：小编
The momentum behind innovative drug concept stocks remains robust. Weikang Pharmaceutical has surged to its 20% daily limit, and Thalys Medical has also hit its daily limit. Additionally, Nanxin Pharmaceutical, Lianhuan Pharmaceutical, Anglikang, and Boji Pharmaceutical, among others, have seen significant gains, echoing the broader trend.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
